The Royal Peptide Labs Research Compendium

LL-37 is a human cathelicidin antimicrobial peptide extensively studied for its multifaceted roles in innate immunity, inflammation, and tissue remodeling within research contexts.

Nicotinamide Mononucleotide (NMN) is extensively investigated as a nicotinamide adenine dinucleotide (NAD+) precursor, with research exploring its influence across fundamental cellular processes in various preclinical models.

This reference provides an in-depth exploration of Triptorelin’s decapeptide molecular structure, chemical properties, and its role as a GnRH agonist in various research contexts.

Noopept (GVS-111) is a dipeptide nootropic compound extensively investigated in preclinical models for its potential cognitive and neuroprotective properties.

This document provides a comprehensive research-focused comparison of Selank and PE-22-28, examining their distinct molecular targets and observed effects in various preclinical models.

PE-22-28 is a spadin-derived peptide under active investigation for its neurobiological implications, particularly within the context of TREK-1 channel modulation and its relevance to cognitive processes.

Myostatin (GDF-8) is a critical growth-differentiation factor extensively studied for its influence on muscle mass regulation, offering insights for regenerative biology research.

Responsible sourcing and rigorous selection criteria are paramount for ensuring the integrity and reproducibility of research involving Hexarelin.

Tabimorelin operates primarily as an orally active growth hormone secretagogue, functioning through the activation of the growth hormone secretagogue receptor 1a (GHS-R1a) to stimulate growth hormone release.

LL-37, a human cathelicidin peptide, exhibits complex half-life and stability profiles influenced by enzymatic activity, environmental factors, and formulation considerations critical for research applications.